Fluidigm Corporation (FLDM): Price and Financial Metrics


Fluidigm Corporation (FLDM): $5.13

0.54 (+11.76%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

FLDM POWR Grades


  • Value is the dimension where FLDM ranks best; there it ranks ahead of 73.34% of US stocks.
  • FLDM's strongest trending metric is Quality; it's been moving down over the last 199 days.
  • FLDM ranks lowest in Sentiment; there it ranks in the 8th percentile.

FLDM Stock Summary

  • With a year-over-year growth in debt of 59.02%, Fluidigm Corp's debt growth rate surpasses 86.21% of about US stocks.
  • As for revenue growth, note that FLDM's revenue has grown 17.83% over the past 12 months; that beats the revenue growth of 75.54% of US companies in our set.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for FLDM comes in at -6.43% -- higher than that of 26.13% of stocks in our set.
  • Stocks that are quantitatively similar to FLDM, based on their financial statements, market capitalization, and price volatility, are SBBP, LTRX, ICAD, AEHR, and LEAF.
  • FLDM's SEC filings can be seen here. And to visit Fluidigm Corp's official web site, go to www.fluidigm.com.

FLDM Price Target

For more insight on analysts targets of FLDM, see our FLDM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $10.33 Average Broker Recommendation 1.33 (Strong Buy)

FLDM Stock Price Chart Interactive Chart >

Price chart for FLDM

FLDM Price/Volume Stats

Current price $5.13 52-week high $12.45
Prev. close $4.59 52-week low $3.33
Day low $4.03 Volume 4,537,200
Day high $5.14 Avg. volume 2,384,144
50-day MA $4.59 Dividend yield N/A
200-day MA $6.19 Market Cap 384.56M

Fluidigm Corporation (FLDM) Company Bio


Fluidigm Corporation develops, manufactures, and markets life science analytical and preparatory systems for growth markets such as single-cell biology and production genomics. The company was founded in 1999 and is based in South San Francisco, California.


FLDM Latest News Stream


Event/Time News Detail
Loading, please wait...

FLDM Latest Social Stream


Loading social stream, please wait...

View Full FLDM Social Stream

Latest FLDM News From Around the Web

Below are the latest news stories about Fluidigm Corp that investors may wish to consider to help them evaluate FLDM as an investment opportunity.

Spring Cleaning Of My Investing Wheelhouse

Photo by AsiaVision/E+ via Getty Images The psychological side of investing In an attempt to keep the word I gave to myself at the beginning of 2021, I return to you with a peek into my stock-picking and backtesting exercises. I am making progress in keeping a better track of...

Magdalena Pacholska on Seeking Alpha | April 30, 2021

How Many Fluidigm Corporation (NASDAQ:FLDM) Shares Do Institutions Own?

Every investor in Fluidigm Corporation ( NASDAQ:FLDM ) should be aware of the most powerful shareholder groups...

Yahoo | April 16, 2021

Fluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial Results

SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report first quarter 2021 financial results on Thursday, May 6, 2021, after the close of the market. Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will host a conference call and webcast at 2:00 p.m. PT, 5:00 p.m. ET, on May 6, 2021, to discuss first quarter 2021 financial results and operational progress. A press release outlining the financial results will be publicly distributed before the call. Individuals interested in listening to the conference call may do so by dialing: US domestic callers: (877) 556-5248Outside...

Yahoo | April 8, 2021

3 Extraordinary Diagnostics Stocks for 2021

Medical diagnostics is not the buzziest sector around. The three companies I'll discuss today are making highly innovative products that are significantly different from the competition, in terms of either their cost or their features. Microeconomics holds that as the cost of a product or service drops, demand for it tends to increase, and that's exactly what Nano-X Imaging (NASDAQ: NNOX) is banking on with its cheap X-ray machines.

Yahoo | March 21, 2021

Single-Cell Genome Sequencing (SCGS) Market – 2027 Top Companies - 10x Genomics, BD, BGI, Bio-Rad Laboratories, Inc., Fluidigm, Novogene Corporation, Oxford Nanopore Technologies, QIAGEN, Takara Bio Inc

Single-Cell Genome Sequencing (SCGS) Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis

OpenPR | March 16, 2021

Read More 'FLDM' Stories Here

FLDM Price Returns

1-mo 11.52%
3-mo -26.50%
6-mo -10.63%
1-year 21.56%
3-year -10.16%
5-year -44.30%
YTD -14.50%
2020 72.41%
2019 -59.63%
2018 46.35%
2017 -19.09%
2016 -32.65%

Continue Researching FLDM

Want to see what other sources are saying about Fluidigm Corp's financials and stock price? Try the links below:

Fluidigm Corp (FLDM) Stock Price | Nasdaq
Fluidigm Corp (FLDM) Stock Quote, History and News - Yahoo Finance
Fluidigm Corp (FLDM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8172 seconds.